Study on direct powder compression of aspirin tablet;
目的粉末直接压片法研究制备头孢克肟片。
In the other part, the improvement of dissolubility of sulfadiazine and aspirin enteric-coated tablet is studied with surfactant as modifier.
然后以磺胺嘧啶片和阿司匹林肠溶片的溶出为例，就表面活性剂的增溶作用进行了考察。
The dissolution of 27(?) lots of aspirin enteric-coated tablet and SMZ Co. Tabletmade by 9 factories was determined with ultraviolet spectrophotometry.
本文用紫外分光光度法对9个厂家27个批号的阿斯匹林肠溶衣片和复方新诺明片进行了体外溶出度测定。
CONCLUSION: the amount, particle size and viscosity of HPMC, preparation method, tablet size as well as the additives significantly influenced aspirin release from HPMC matrix tablet.
结论：HPMC用量、粘度和粒度、制片方法、片剂大小及其它辅料为影响阿司匹林骨架片释放速率的主要因素。
The healthy subjects, aged 40 to 84 years and free of asthma at baseline in 1982, were randomly assigned to a single 325-mg tablet of aspirin or placebo on alternate days.
基线1982年时，所有受试者年龄为40~84岁，健康、无哮喘，随机接受隔日一次的单片剂量为325 mg的阿司匹林或安慰剂。
The healthy subjects, aged 40 to 84 years and free of asthma at baseline in 1982, were randomly assigned to a single 325-mg tablet of aspirin or placebo on alternate days.
基线1982年时，所有受试者年龄为40~84岁，健康、无哮喘，随机接受隔日一次的单片剂量为325 mg的阿司匹林或安慰剂。
应用推荐